Correlation Between Neximmune and Cognition Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neximmune and Cognition Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Cognition Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and Cognition Therapeutics, you can compare the effects of market volatilities on Neximmune and Cognition Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Cognition Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Cognition Therapeutics.
Diversification Opportunities for Neximmune and Cognition Therapeutics
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Neximmune and Cognition is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Cognition Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cognition Therapeutics and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Cognition Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cognition Therapeutics has no effect on the direction of Neximmune i.e., Neximmune and Cognition Therapeutics go up and down completely randomly.
Pair Corralation between Neximmune and Cognition Therapeutics
Given the investment horizon of 90 days Neximmune is expected to generate 2.45 times more return on investment than Cognition Therapeutics. However, Neximmune is 2.45 times more volatile than Cognition Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Cognition Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 1,050 in Neximmune on August 27, 2024 and sell it today you would lose (807.00) from holding Neximmune or give up 76.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 79.78% |
| Values | Daily Returns |
Neximmune vs. Cognition Therapeutics
Performance |
| Timeline |
| Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cognition Therapeutics |
Neximmune and Cognition Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neximmune and Cognition Therapeutics
The main advantage of trading using opposite Neximmune and Cognition Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Cognition Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cognition Therapeutics will offset losses from the drop in Cognition Therapeutics' long position.| Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
| Cognition Therapeutics vs. Reviva Pharmaceuticals Holdings | Cognition Therapeutics vs. Eyenovia | Cognition Therapeutics vs. Transcode Therapeutics | Cognition Therapeutics vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |